CPhI South East Asia Indicates Rapid Pharma Sector Growth for the ASEAN
AMSTERDAM, April 18, 2013 /PRNewswire/ --
Record numbers, a focus on development initiatives and analysis of the regional harmonisation programme helps stimulate increased partnerships
CPhI, a division of UBM Live, announces that this year's recent CPhI South East Asia 2013, which ran from 20-22nd March at the Jakarta International Expo in Indonesia, was the most successful so far. The event, which is the region's go to networking opportunity and a hot bed of pharmaceutical innovation, attracted more than 5500 visitors from 51 countries and regions meeting over 260 exhibitors from 25 countries and regions around the world.
The strong international focus at CPhI South East Asia is representative of the expanding pharma sector within the region and was enhanced by new co-located events, including: PMEC for pharmaceutical machinery laboratory equipment and analytical technology; and InnoPack South East Asia for innovative packaging and drug delivery solutions.
"The pharma market in South East Asia is experiencing a very dynamic period with growth of both domestic manufacturing and international trade. We therefore designed CPhI South East Asia 2013 to reflect these sweeping changes and ran a series of high level conferences alongside the exhibition enabling participants to hear the latest thinking on pressing issues, including: the impending ASEAN harmonisation due in 2015; cross-border trade and regulatory arbitrage; IPR protection; and perspectives on the pharmerging markets, regional consumer trends, the growth of generics and regional manufacturing," commented Martin Wilson, UBM Live Brand Director.
A crucial element of the ASEAN region's development, which is predicted to reach a market value of US$80 billion by 2017, will be the establishing of close regional partnerships and cross-sharing of information between companies. CPhI South East Asia recognised this evolving landscape and is the only dedicated event for the region where ideas and business opportunities can be exchanged. Furthermore, local Governments have lent their support to the event as they aim to implement initiatives for increased domestic production particularly focussed on generics and a tighter regulatory landscape aimed at reducing anti-counterfeiting issues. Coupled with a growing economic affluence and cross border trade means the region is at the precipice of an explosion of growth.
The increase in exhibitors, internationally credible speakers and visitors highlights the immense strides countries here have made in manufacturing standards, increased commitment to standardised regulation, improved packaging technologies, and legislation protecting intellectual property - crucial to safeguarding innovation - and improving safety standards.
Martin added: "CPhI as a whole is mirroring changes in South East Asia and our aim is to help facilitate the adoption of new technologies and partnerships needed to help meet the Government backed demands of an increasing standardised regulatory arena and greater domestic production of pharmaceuticals. With a rapidly reforming healthcare landscape this event will continue to grow next year and help build the region as a manufacturing base and source of biotech and pharmaceutical innovation."
CPhI South East Asia will return to the Jakarta International Expo from 20-22nd May 2014 and UBM Live looks forward to bringing its international pharma event back to one of the world's most dynamically evolving regions.
The UBM Live annual schedule of Pharmaceutical events also includes CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (24-26 April, 2013 at the Tokyo Big Sight Exhibition Centre in Japan); CPhI, P-MEC, ICSE, InnoPack and BioPh China (25-27 June, 2013 at the SNIEC in Shanghai, China); CPhI, ICSE and BioPh South America (06-08 August, 2013 at the Expo Center Norte in Sao Paulo, Brazil); CPhI Worldwide, ICSE, P-MEC Europe and InnoPack (22-24 October, 2012 at Messe Frankfurt, Germany); and CPhI and P-MEC India (03-05 December, 2013 at the Bombay Exhibition Centre in Mumbai).
Notes to the editor
CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, China, India, Japan, Southeast Asia, Russia and South America and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com and hosts a global community with news and analysis at PharmaEvolution.com, produced by UBM Live and partners.
For more information visit: http://www.cphi.com
About UBM Live
UBM Live connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.
SOURCE UBM Live